Hormone-refractory prostate cancer: An evolving standard of care

被引：0
|
作者：
Small, EJ
Reese, DM
Vogelzang, NJ
机构：
[1] Univ Calif San Francisco, UCSF Comprehens Canc Ctr, San Francisco, CA 94115 USA
[2] Univ Chicago, Ctr Canc Res, Chicago, IL 60637 USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：61 / 67
页数：7
相关论文
共 50 条
  • [41] METRONOMIC CYCLOPHOSPHAMIDE IN HORMONE-REFRACTORY PROSTATE CANCER
    Baldazzi, Valentina
    Tassi, Renato
    Lapini, Alberto
    Lunghi, Alice
    Carini, Marco
    Mazzanti, Roberto
    ANTICANCER RESEARCH, 2010, 30 (04) : 1459 - 1460
  • [42] New therapeutic agents for hormone-refractory prostate cancer
    Roth, BJ
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 49 - 55
  • [43] Differential gene expression in hormone-refractory prostate cancer
    Fromont, G
    Chene, L
    Vidaud, M
    Mahouche, I
    Vallancien, G
    Validire, P
    Latil, A
    Cussenot, O
    MODERN PATHOLOGY, 2003, 16 (01) : 150A - 150A
  • [44] Predictive modelling in hormone-refractory prostate cancer (HRPC)
    Bellmunt, Joaquim
    Carles, Joan
    Albanell, Joan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (02): : 82 - 85
  • [45] Future therapies in hormone-refractory prostate cancer - Discussion
    DiPaola, RS
    Carducci, MA
    Smith, MR
    Nelson, JB
    Thompson, IM
    UROLOGY, 2005, 65 (5A) : 17 - 17
  • [46] Update in the management of patients with hormone-refractory prostate cancer
    Moore, CN
    George, DJ
    CURRENT OPINION IN UROLOGY, 2005, 15 (03) : 157 - 162
  • [47] The role of urologists in the management of hormone-refractory prostate cancer
    Pummer, K
    EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (02) : 24 - 28
  • [48] Predictive modelling in hormone-refractory prostate cancer (HRPC)
    Joaquim Bellmunt
    Joan Carles
    Joan Albanell
    Clinical and Translational Oncology, 2009, 11 : 82 - 85
  • [49] Chromogranin A predicts development of hormone-refractory prostate cancer
    Nature Clinical Practice Urology, 2007, 4 (11): : 581 - 581
  • [50] Targeted therapy in hormone-refractory prostate cancer (HPRC)
    Sternberg, C. N.
    ANNALS OF ONCOLOGY, 2007, 18 : 21 - 21
12345